Table of Contents

1 Report Overview

• 1.1 Research Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Rupatadine Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 5 mg Tablets
  • 1.3.3 10 mg Tablets
  • 1.3.4 20 mg tablets
• 1.4 Market Segment by Application
  • 1.4.1 Global Rupatadine Market Share by Application (2019-2025)
  • 1.4.2 Adults
  • 1.4.3 Adolescents
  • 1.4.4 Other
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Production and Capacity Analysis
  • 2.1.1 Global Rupatadine Production Value 2014-2025
  • 2.1.2 Global Rupatadine Production 2014-2025
  • 2.1.3 Global Rupatadine Capacity 2014-2025
  • 2.1.4 Global Rupatadine Marketing Pricing and Trends
• 2.2 Key Producers Growth Rate (CAGR) 2019-2025
  • 2.2.1 Global Rupatadine Market Size CAGR of Key Regions
  • 2.2.2 Global Rupatadine Market Share of Key Regions
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Capacity and Production by Manufacturers
  • 3.1.1 Global Rupatadine Capacity by Manufacturers
  • 3.1.2 Global Rupatadine Production by Manufacturers
• 3.2 Revenue by Manufacturers
  • 3.2.1 Rupatadine Revenue by Manufacturers (2014-2019)
  • 3.2.2 Rupatadine Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Rupatadine Market Concentration Ratio (CR5 and HHI)
• 3.3 Rupatadine Price by Manufacturers
• 3.4 Key Manufacturers Rupatadine Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Rupatadine Market
• 3.6 Key Manufacturers Rupatadine Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Production and Production Value for Each Type
  • 4.1.1 5 mg Tablets Production and Production Value (2014-2019)
  • 4.1.2 10 mg Tablets Production and Production Value (2014-2019)
  • 4.1.3 20 mg tablets Production and Production Value (2014-2019)
• 4.2 Global Rupatadine Production Market Share by Type
• 4.3 Global Rupatadine Production Value Market Share by Type
• 4.4 Rupatadine Ex-factory Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Rupatadine Consumption by Application

6 Production by Regions

• 6.1 Global Rupatadine Production (History Data) by Regions 2014-2019
• 6.2 Global Rupatadine Production Value (History Data) by Regions
• 6.3 United States
  • 6.3.1 United States Rupatadine Production Growth Rate 2014-2019
  • 6.3.2 United States Rupatadine Production Value Growth Rate 2014-2019
  • 6.3.3 Key Players in United States
  • 6.3.4 United States Rupatadine Import & Export
• 6.4 European Union
  • 6.4.1 European Union Rupatadine Production Growth Rate 2014-2019
  • 6.4.2 European Union Rupatadine Production Value Growth Rate 2014-2019
  • 6.4.3 Key Players in European Union
  • 6.4.4 European Union Rupatadine Import & Export
• 6.5 China
  • 6.5.1 China Rupatadine Production Growth Rate 2014-2019
  • 6.5.2 China Rupatadine Production Value Growth Rate 2014-2019
  • 6.5.3 Key Players in China
  • 6.5.4 China Rupatadine Import & Export
• 6.6 Rest of World
  • 6.6.1 Japan
  • 6.6.2 Korea
  • 6.6.3 India
  • 6.6.4 Southeast Asia

7 Rupatadine Consumption by Regions

• 7.1 Global Rupatadine Consumption (History Data) by Regions
• 7.2 United States
  • 7.2.1 United States Rupatadine Consumption by Type
  • 7.2.2 United States Rupatadine Consumption by Application
• 7.3 European Union
  • 7.3.1 European Union Rupatadine Consumption by Type
  • 7.3.2 European Union Rupatadine Consumption by Application
• 7.4 China
  • 7.4.1 China Rupatadine Consumption by Type
  • 7.4.2 China Rupatadine Consumption by Application
• 7.5 Rest of World
  • 7.5.1 Rest of World Rupatadine Consumption by Type
  • 7.5.2 Rest of World Rupatadine Consumption by Application
  • 7.5.1 Japan
  • 7.5.2 Korea
  • 7.5.3 India
  • 7.5.4 Southeast Asia

8 Company Profiles

• 8.1 GlaxoSmithKline
  • 8.1.1 GlaxoSmithKline Company Details
  • 8.1.2 Company Description and Business Overview
  • 8.1.3 Production and Revenue of Rupatadine
  • 8.1.4 Rupatadine Product Introduction
  • 8.1.5 GlaxoSmithKline Recent Development
• 8.2 Teikoku Seiyaku
  • 8.2.1 Teikoku Seiyaku Company Details
  • 8.2.2 Company Description and Business Overview
  • 8.2.3 Production and Revenue of Rupatadine
  • 8.2.4 Rupatadine Product Introduction
  • 8.2.5 Teikoku Seiyaku Recent Development
• 8.3 Incepta
  • 8.3.1 Incepta Company Details
  • 8.3.2 Company Description and Business Overview
  • 8.3.3 Production and Revenue of Rupatadine
  • 8.3.4 Rupatadine Product Introduction
  • 8.3.5 Incepta Recent Development
• 8.4 Aristopharma
  • 8.4.1 Aristopharma Company Details
  • 8.4.2 Company Description and Business Overview
  • 8.4.3 Production and Revenue of Rupatadine
  • 8.4.4 Rupatadine Product Introduction
  • 8.4.5 Aristopharma Recent Development
• 8.5 Orion Pharma
  • 8.5.1 Orion Pharma Company Details
  • 8.5.2 Company Description and Business Overview
  • 8.5.3 Production and Revenue of Rupatadine
  • 8.5.4 Rupatadine Product Introduction
  • 8.5.5 Orion Pharma Recent Development
• 8.6 Yangtze River Pharmaceutical Group
  • 8.6.1 Yangtze River Pharmaceutical Group Company Details
  • 8.6.2 Company Description and Business Overview
  • 8.6.3 Production and Revenue of Rupatadine
  • 8.6.4 Rupatadine Product Introduction
  • 8.6.5 Yangtze River Pharmaceutical Group Recent Development
• 8.7 Tyche Industries Limited
  • 8.7.1 Tyche Industries Limited Company Details
  • 8.7.2 Company Description and Business Overview
  • 8.7.3 Production and Revenue of Rupatadine
  • 8.7.4 Rupatadine Product Introduction
  • 8.7.5 Tyche Industries Limited Recent Development

9 Market Forecast

• 9.1 Global Market Size Forecast
  • 9.1.1 Global Rupatadine Capacity, Production Forecast 2019-2025
  • 9.1.2 Global Rupatadine Production Value Forecast 2019-2025
• 9.2 Market Forecast by Regions
  • 9.2.1 Global Rupatadine Production and Value Forecast by Regions 2019-2025
  • 9.2.2 Global Rupatadine Consumption Forecast by Regions 2019-2025
• 9.3 United States
  • 9.3.1 Production and Value Forecast in United States
  • 9.3.2 Consumption Forecast in United States
• 9.4 European Union
  • 9.4.1 Production and Value Forecast in European Union
  • 9.4.2 Consumption Forecast in European Union
• 9.5 China
  • 9.5.1 Production and Value Forecast in China
  • 9.5.2 Consumption Forecast in China
• 9.6 Rest of World
  • 9.6.1 Japan
  • 9.6.2 Korea
  • 9.6.3 India
  • 9.6.4 Southeast Asia
• 9.7 Forecast by Type
  • 9.7.1 Global Rupatadine Production Forecast by Type
  • 9.7.2 Global Rupatadine Production Value Forecast by Type
• 9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis

• 10.1 Value Chain Analysis
• 10.2 Sales Channels Analysis
  • 10.2.1 Rupatadine Sales Channels
  • 10.2.2 Rupatadine Distributors
• 10.3 Rupatadine Customers

11 Opportunities & Challenges, Threat and Affecting Factors

• 11.1 Market Opportunities
• 11.2 Market Challenges
• 11.3 Porter's Five Forces Analysis

12 Key Findings

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details

In 2019, the market size of Rupatadine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Rupatadine.

This report studies the global market size of Rupatadine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Rupatadine production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GlaxoSmithKline
Teikoku Seiyaku
Incepta
Aristopharma
Orion Pharma
Yangtze River Pharmaceutical Group
Tyche Industries Limited
...

Market Segment by Product Type
5 mg Tablets
10 mg Tablets
20 mg tablets

Market Segment by Application
Adults
Adolescents
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Rupatadine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Rupatadine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Rupatadine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025